About the journal
npj Vaccines is an open-access journal published by Nature Portfolio in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 3,590 EUR. Declared review time at DOAJ: 11 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Nature Portfolio
- ISSN
- 2059-0105
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,590 EUR
- Articles in DOAJ
- 1259
- Declared review time
- 11 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.nature.com/npjvaccines/
Index listings
- DOAJ · 2017-01-03
- PUBMED · 2017-03-08
- Indexing
- DOAJ · PUBMED
- APC
- 3,590 EUR
- Declared review time (DOAJ)
- 11 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
1259
Most recent article
last month
Average review time (journal-declared via DOAJ)
11weeks
Works in OpenAlex
1511
Last recorded publication year
2026
h-index
81
i10-index
772
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2017-01-03
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 86%
- ORCID iDs in current deposits
- 43%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Nature Partner Journals vaccinesVaccines
- Source type
- journal
- NLM unique ID (PubMed)
- 101699863
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 and COVID-19 Research
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Influenza Virus Research Studies
- Influenza Virus Research Studies
- Mosquito-borne diseases and control
- Mosquito-borne diseases and control
Show all subjects (50)
- Respiratory viral infections research
- Respiratory viral infections research
- Viral gastroenteritis research and epidemiology
- Viral gastroenteritis research and epidemiology
- vaccines and immunoinformatics approaches
- vaccines and immunoinformatics approaches
- Viral Infections and Vectors
- Viral Infections and Vectors
- Animal Virus Infections Studies
- Animal Virus Infections Studies
- Viral Infections and Outbreaks Research
- Viral Infections and Outbreaks Research
- Vaccine Coverage and Hesitancy
- Vaccine Coverage and Hesitancy
- Malaria Research and Control
- COVID-19 Clinical Research Studies
- Malaria Research and Control
- COVID-19 Clinical Research Studies
- HIV Research and Treatment
- HIV Research and Treatment
- Virology and Viral Diseases
- Virology and Viral Diseases
- Immune responses and vaccinations
- Immune responses and vaccinations
- Immune Response and Inflammation
- Immune Response and Inflammation
- Viral Infections and Immunology Research
- Viral Infections and Immunology Research
- RNA Interference and Gene Delivery
- Bacterial Infections and Vaccines
- RNA Interference and Gene Delivery
- Bacterial Infections and Vaccines
- Pneumonia and Respiratory Infections
- Pneumonia and Respiratory Infections
- Herpesvirus Infections and Treatments
- Herpesvirus Infections and Treatments
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
Keywords (DOAJ)
- oncology vaccines
- aids vaccine
- vaccine safety
- vaccine formulation
- vaccine adjuvants
- veterinary vaccines
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ